John Welter

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Harry Heijerman, Edward F. McKone, D.G. Downey et al. · The Lancet · 2019 · 1.3K citations · Full text

Mendelian Disorder, Genetics, Ivacaftor Combination Regimen +2

Canine distemper virus (CDV) infection of ferrets as a model for testing Morbillivirus vaccine strategies: NYVAC- and ALVAC-based CDV recombinants protect against symptomatic infection

Charles B. Stephensen, John Welter, S. R. Thaker et al. · Journal of Virology · 1997 · 104 citations · Full text

Vaccination, Morbillivirus Vaccine Strategies, Veterinary Vaccine +14

Azithromycin for Early <i>Pseudomonas</i> Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial

Nicole Mayer-Hamblett, George Retsch‐Bogart, Margaret Kloster et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 96 citations · Full text

Staphylococcus aureus Nasal Colonization Among Pediatric Cystic Fibrosis Patients and Their Household Contacts

Anne Stone, Lynne M. Quittell, Juyan Zhou et al. · The Pediatric Infectious Disease Journal · 2009 · 33 citations

[Staged lavage therapy in diffuse peritonitis].

W. Teichmann, A Eggert, John Welter et al. · PubMed · 1982 · 15 citations